본문으로 건너뛰기
← 뒤로

Targeting Cancers with Microrobots and Bacteriobots.

Molecular biotechnology 2026 Vol.68(4) p. 1699-1717

Pal A, Sonowane R, Ramakrishna W

📝 환자 설명용 한 줄

Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Pal A, Sonowane R, Ramakrishna W (2026). Targeting Cancers with Microrobots and Bacteriobots.. Molecular biotechnology, 68(4), 1699-1717. https://doi.org/10.1007/s12033-025-01488-4
MLA Pal A, et al.. "Targeting Cancers with Microrobots and Bacteriobots.." Molecular biotechnology, vol. 68, no. 4, 2026, pp. 1699-1717.
PMID 40770161

Abstract

Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.

MeSH Terms

Humans; Neoplasms; Drug Delivery Systems; Tumor Microenvironment; Robotics; Antineoplastic Agents; Animals

같은 제1저자의 인용 많은 논문 (2)